Toll-like receptor signalling on Tregs: To suppress or not to suppress?

Immunology

Volumn 124, Issue 4, 2008, Pages 445-452

  Van Maren, Wendy W C ^b   Jacobs, Joannes F M ^b   De Vries, I Jolanda M ^b   Nierkens, Stefan ^b   Adema, Gosse J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Immunotherapeutics; Regulatory T cell; Toll like receptor

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TOLL LIKE RECEPTOR;

BACTERIUM; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; FUNGUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOON; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH3 CELL; VIRUS;

HUMANS; IMMUNE TOLERANCE; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 46949091694     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02871.x     Document Type: Review

References (90)

1. Ausubel FM. Are innate immune signaling pathways in plants and animals conserved? Nat Immunol 2005 6 : 973 9.
2. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004 5 : 987 95.
3. Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol 2004 16 : 23 6.
4. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006 84 : 712 25.
5. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003 85 : 85 95.
6. Liu G, Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+CD25+ T cells. Immunology 2007 122 : 149 56.
7. Yarovinsky F, Zhang D, Andersen JF et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005 308 : 1626 9.
8. Lauw FN, Caffrey DR, Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005 26 : 509 11.
9. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR. Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006 116 : 2022 32.
10. Asea A, Rehli M, Kabingu E et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002 277 : 15028 34.
11. Vabulas RM, Braedel S, Hilf N et al. The endoplasmatic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002 277 : 20847 53.
12. Nishiya T, Kajita E, Miwa S, Defranco AL. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem 2005 280 : 37107 17.
13. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001 167 : 2887 94.
14. Biragyn A, Ruffini PA, Leifer CA et al. Toll-like receptor 4-dependant activation of dendritic cells by beta-defensin 2. Science 2002 298 : 1025 9.
15. Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependant and -independant dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004 199 : 1631 40.
16. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002 2 : 1 7.
17. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003 193 : 70 81.
18. Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007 38 : 112 21.
19. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003 170 : 3939 43.
20. Morgan ME, Flierman R, van Duivenvoorde LM et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005 52 : 2212 21.
21. Dannull J, Su Z, Rizzieri D. Enhancement of vaccine-mediated anti-tumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005 115 : 3623 33.
22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). J Immunol 1995 155 : 1151 64.
23. Taams LS, van Amelsfort JM, Tiemessen MM et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol 2005 33 : 222 30.
24. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000 164 : 183 90.
25. Sakaguchi S. Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005 6 : 345 52.
26. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science 2003 299 : 1057 61.
27. Gray JD, Hirokawa M, Horwitz DA. The role of transforming growth factor-beta in the generation of suppression: an interaction between CD8+ T and NK cells. Microbes Infect 1999 1 : 1305 11.
28. Zheng SG, Wang JH, Koss MN, Quismorio F Jr, Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory Graft-versus-Host disease with a Lupus-like syndrome. J Immunol 2004 172 : 1531 9.
29. Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 2008 205 : 565 74.
30. Ono M, Yaguchi H, Ohkura N et al. FoxP3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007 446 : 685 9.
31. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006 24 : 209 26.
32. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000 192 : 295 302.
33. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002 3 : 135 42.
34. Allakhverdi Z, Fitzpatrick D, Boisvert A et al. Expression of CD103 identifies human regulatory T-cell subsets. J Allergy Clin Immunol 2006 118 : 1342 9.
35. Annunziato F, Cosmi L, Liotta F et al. Phenotype, localization, and mechanisms of suppression of CD4+CD25+ human thymocytes. J Exp Med 2002 196 : 379 87.
36. Groux H, Bigler M, O'Garra A et al. A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997 389 : 737 42.
37. Wakkach A, Fournier N, Brun V, Breittmayer J-P, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003 18 : 605 17.
38. Awasthi A, Carrier Y, Person JPS et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007 8 : 1380 9.
39. Astier AL, Hafler DA. Abnormal Tr1 differentiation in multiple sclerosis. J Neuroimmunol 2007 191 : 70 8.
40. Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002 195 : 603 16.
41. Chen WJ, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor FoxP3. J Exp Med 2003 198 : 1875 86.
42. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through FoxP3 induction and down-regulation of Smad7. J Immunol 2004 172 : 5149 53.
43. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007 178 : 179 85.
44. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol 2007 178 : 172 8.
45. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious Tolerance: Human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med 2002 196 : 255 60.
46. Saitoh O, Abiru N, Nakahara M, Nagayama Y. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrinology 2007 148 : 6040 6.
47. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gamma-delta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007 27 : 334 48.
48. Nakamura K, Kitani A, Strober W. Cell contact-dependant immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001 194 : 629 44.
49. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independant mechanism. J Immunol 2005 174 : 1783 6.
50. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 21 : 589 601.
51. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005 6 : 338 44.
52. Borsellino G, Kleinewietfeld M, Di Mitri D et al. Expression of ectonucleotidase CD39 by FoxP3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007 110 : 1225 32.
53. Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007 204 : 1257 65.
54. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 2006 177 : 6780 6.
55. Ren X, Ye F, Jiang Z, Chu Y, Xiong S, Wang Y. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+CD25+ regulatory T cells. Cell Death Differ 2007 14 : 2076 84.
56. Kubach J, Lutter P, Bopp T et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 2007 110 : 1550 8.
57. Grader-Beck T, van Puijenbroek AAFL, Nadler LM, Boussiotis VA. cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Blood 2007 101 : 998 1006.
58. Bopp T, Becker C, Klein M et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007 204 : 1303 10.
59. Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 450 : 566 9.
60. Sutmuller RPM, Morgan ME, Netea MG, Grauer O, Adema GJ. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 2006 27 : 387 93.
61. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004 173 : 7249 58.
62. Scheffold A, Hühn J, Höfer T. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. Eur J Immunol 2005 35 : 1336 41.
63. Kabelitz D. Expression and function of toll-like receptors in T lymphocytes. Curr Opin Immunol 2007 19 : 39 45.
64. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003 197 : 403 11.
65. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. PNAS 2004 101 : 3029 34.
66. Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FoxP3 in CD4+CD25+ T regulatory cells. J Immunol 2005 175 : 8051 9.
67. Sutmuller RPM, den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006 116 : 485 94.
68. Liu H, Komai-Koma M, Xu D, Lauw FN. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. PNAS 2006 103 : 7048 53.
69. Peng G, Guo Z, Kiniwa Y et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005 309 : 1380 4.
70. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreider RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002 3 : 991 8.
71. Croci DO, Zacarias Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 2007 56 : 1687 700.
72. Knutson KL, Disis ML, Salazar LG. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 2007 56 : 271 85.
73. Wei S, Kryczek I, Zou L et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005 65 : 5020 6.
74. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003 3 : 211 22.
75. Smyth MJ, Godfrey DI. NKT cells and tumor immunity - a double-edged sword. Nat Immunol 2000 1 : 459 60.
76. Wang HY, Peng G, Guo Z et al. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J Immunol 2005 174 : 2661 70.
77. Wang HY, Lee DA, Peng G et al. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004 20 : 107 18.
78. Straten P, Becker JC, Guldberg P et al. In situ T cells in melanoma. Cancer Immunol Immunother 1999 48 : 386 95.
79. Balch CM, Riley LB, Bae YJ et al. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990 125 : 200 5.
80. Sawamura Y, de Tribolet N. Immunobiology of brain tumors. Adv Tech Stand Neurosurg 1990 17 : 3 64.
81. Sutmuller RPM, van Duivenvoorde LM, van Elsas A et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte response. J Exp Med 2001 194 : 823 32.
82. Grauer O, Nierkens S, Bennink E et al. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune response in vivo. Int J Cancer 2007 121 : 95 105.
83. El Andaloussi A, Han Y, Lesniak MS. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. J Neurosurg 2006 105 : 430 7.
84. Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999 163 : 5211 8.
85. Betts G, Twohig J, Van den Broek M et al. The impact of regulatory T cells on carcinogen-induced sarcogenesis. Br J Cancer 2007 96 : 1849 54.
86. van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol 2006 27 : 49 55.
87. Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P. Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 2007 13 : 4565 74.
88. Jego G, Bataille R, Geffroy-Luseau A, Descamps G, Pellat-Deceunynck C. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia 2006 20 : 1130 7.
89. El Andaloussi A, Sonabend AM, Han Y, Lesniak MS. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia 2006 54 : 526 35.
90. Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005 295 : 179 85.